For the readers interested in the stock health of Bionano Genomics Inc. (BNGO). It is currently valued at $2.18. When the transactions were called off in the previous session, Stock hit the highs of $2.22, after setting-off with the price of $2.16. Company’s stock value dipped to $2.09 during the trading on the day. When the trading was stopped its value was $2.17.Recently in News on September 14, 2022, Bionano Genomics Announces Publication of Study in MDS and AML Showing Utility for Refined Diagnostics and Prognostic Stratification. Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study evaluating the performance of OGM for detection of cytogenetic abnormalities in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) samples. This work is the second independent study, following a recent publication from researchers at MD Anderson Cancer Center, showing that OGM enables better molecular characterization of MDS. This paper extends that research to AML and the findings indicate that OGM may have an even greater impact on the characterization of AML compared to MDS, which led the researchers to recommend integrating OGM into new prognostic scoring methods for both myeloid malignancies. You can read further details here
Bionano Genomics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.35 on 08/11/22, with the lowest value was $1.16 for the same time period, recorded on 05/12/22.
Bionano Genomics Inc. (BNGO) full year performance was -60.97%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Bionano Genomics Inc. shares are logging -65.28% during the 52-week period from high price, and 87.93% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.16 and $6.28.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1371603 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Bionano Genomics Inc. (BNGO) recorded performance in the market was -27.42%, having the revenues showcasing 51.75% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 663.46M, as it employees total of 299 workers.
Analysts verdict on Bionano Genomics Inc. (BNGO)
During the last month, 4 analysts gave the Bionano Genomics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.94, with a change in the price was noted +0.53. In a similar fashion, Bionano Genomics Inc. posted a movement of +32.82% for the period of last 100 days, recording 7,476,792 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BNGO is recording 0.01 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.01.
Bionano Genomics Inc. (BNGO): Technical Analysis
Raw Stochastic average of Bionano Genomics Inc. in the period of last 50 days is set at 24.66%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 9.38%. In the last 20 days, the company’s Stochastic %K was 9.56% and its Stochastic %D was recorded 11.24%.
Let’s take a glance in the erstwhile performances of Bionano Genomics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -27.42%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -7.26%, alongside a downfall of -60.97% for the period of the last 12 months. The shares increased approximately by -14.57% in the 7-day charts and went up by -24.91% in the period of the last 30 days. Common stock shares were driven by 51.75% during last recorded quarter.